AI assistant
Sending…
EXPONENT INC — Director's Dealing 2018
Mar 15, 2018
31263_dirs_2018-03-15_a8116be3-a97b-4a11-9bfa-ebc94788a09c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EXPONENT INC (EXPO)
CIK: 0000851520
Period of Report: 2018-03-14
Reporting Person: Osteraas John (Group Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-03-14 | Common Stock | M | 1072 | — | Acquired | 11324 | Direct |
| 2018-03-14 | Common Stock | M | 58 | — | Acquired | 11382 | Direct |
| 2018-03-14 | Common Stock | F | 374 | $79.45 | Disposed | 11008 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-03-14 | Dividend Equivalent Rights | $ | A | 6 | Acquired | 2018-03-14 | Common Stock (6) | Direct |
| 2018-03-14 | Dividend Equivalent Rights | $ | M | 58 | Disposed | 2018-03-14 | Common Stock (58) | Direct |
| 2018-03-14 | Restricted Stock Units | $ | M | 1072 | Disposed | 2018-04-14 | Common Stock (1072) | Direct |
Footnotes
F1: Reflects the conversion of shares of vested Restricted Stock Units granted on March 14, 2014 into shares of Common Stock on a 1:1 basis.
F2: Not applicable.
F3: Settlement of dividend equivalent rights in connection with RSU release on a 1:1 basis.
F4: Reflects shares of common stock withheld by the Company to satify the tax withholding obligations of the Reporting Person.
F5: The dividend equivalent rights accrued with respect to RSUs, pursuant to dividends earned in Q1 2018.
More from EXPONENT INC
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 21
Proxy Solicitation & Information Statement
2026
Apr 20
Regulatory Filings
2026
Apr 6
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Feb 27
Annual Report
2026
Feb 27